Stockreport

Cryoport: Moving Toward Commercial Scalability And Near-Term Breakeven [Seeking Alpha]

CryoPort, Inc.  (CYRX) 
NASDAQ:AMEX Investor Relations: ir.cryoport.com
PDF CYRX demonstrated double-digit revenue growth in Q4 2025, led by Life Sciences Services, and improved gross margins to 47.8%. Management targets positive adjusted EBI [Read more]